1. ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target 
Szu-Chun Hung, Der-Cherng Tarng 
Kidney International 
Volume 86, Issue 4, Pages (October 2014)
DOI: /ki
Copyright © 2014 International Society of Nephrology Terms and Conditions

2. Figure 1
Interaction of patient, erythropoiesis-stimulating agent (ESA), and iron in the management of anemia in chronic kidney disease. Hb, hemoglobin; IV, intravenous.
Kidney International  , DOI: ( /ki )
Copyright © 2014 International Society of Nephrology Terms and Conditions